Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura.
Pediatr Blood Cancer
; 42(1): 109-12, 2004 Jan.
Article
em En
| MEDLINE
| ID: mdl-14752803
ABSTRACT
BACKGROUND:
To determine the clinical features and treatment outcomes of infants with immune thrombocytopenic purpura (ITP).METHODS:
Retrospective analysis of 79 infant ITP patients treated from 1987 to 2002. The data abstracted comprised age, gender, clinical features, and treatment outcomes. A score test for the trend in the odds ratios was used to determine the risk of chronic ITP with advancing age. The infants were compared to a group of contemporaneous older children with regard to bleeding severity and incidence of chronic ITP.RESULTS:
The 34 female and 45 male infants had a median age of 16 months. Seventy-four presented with purpura, four with viral illnesses, and one was asymptomatic. Eight percent had active mucosal bleeding. The median platelet count was 8,000/microl. Forty infants received intravenous immunoglobulin, nine intravenous anti-D immunoglobulin, six steroids, and seven were observed without treatment. Fifty-five (76%) responded to a single course of treatment. Only 9% of infants developed chronic ITP compared to 18% of children between the ages of 25 and 119 months and 47% of children 120 months or older (P<0.0005).CONCLUSIONS:
Infants with ITP respond favorably to treatment and are less likely to develop chronic ITP compared to older children.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Púrpura Trombocitopênica
/
Imunoglobulinas Intravenosas
/
Imunoglobulina rho(D)
/
Anti-Inflamatórios
Tipo de estudo:
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
/
Pregnancy
Idioma:
En
Revista:
Pediatr Blood Cancer
Assunto da revista:
HEMATOLOGIA
/
NEOPLASIAS
/
PEDIATRIA
Ano de publicação:
2004
Tipo de documento:
Article
País de afiliação:
Estados Unidos